Has Randall Lee, MD received payments from drug or device companies?

Yes. Drug and device makers reported $173,859 in general payments to Randall Lee, MD across 164 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Randall Lee, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Randall Lee, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Randall Lee, MD

Clinical Cardiac Electrophysiology · San Francisco, CANPI 1316987472

Payments from drug & device makers

What this record shows

The money is spread across several categories — ownership interests (51.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Boston Scientific at 54.7% of the total. Reporting peaked in 2019 at $105,030 and has fallen 100.0% since, to $41 in 2025.

$173,859in general payments, 2019–2025

Across 164 payments — averaging $1060.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$95K
Atricure, Inc.$65K
Intuitive Surgical$11K
Baylis Medical Company Inc$1K
Abbott$1K
Medtronic$338
plus $471 from 3 others

$216,220in research payments, 2019–2025

Across 8 payments — averaging $27,028 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Atricure, Inc.$216K

What the payments were for

Consulting fees$35,00020%
Speaking & faculty fees$15,8009%
Travel & lodging$28,98117%
Food & beverage$4,4713%
Ownership interest$89,60852%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	9	$95,135
Atricure, Inc.	130	$64,668
Intuitive Surgical	3	$10,800
Baylis Medical Company Inc	1	$1,295
Abbott	14	$1,152
Medtronic	2	$338
Biosense Webster, Inc.	2	$256
Biotronik Inc.	2	$147
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$68

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

GENERAL - THERAPIES$89,608
LARIAT SUTURE DELIVERY DEVICE$42,034
Da Vinci Surgical System$10,500
VersaCross Access Solution$5,207
SYNERGY ABLATION SYSTEM$3,486
NRG needle$1,295
EPI-SENSE GUIDED COAGULATION SYS$908
ATRICURE ATRICLIP LAA EXCLUSION$865
AMPLATZER$692
ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$300
DA VINCI SP$300
COBALT DR MRI SURESCAN$175
AURORA EV-ICD MRI SURESCAN$164
ATRICURE CRYOSURGICAL SYSTEM$161
RESONATE$144
Carto 3$130
ENSITE PRECISION$129
Carto 3 System$127

How this compares

$173,859 in reported general payments places this provider in the 85th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California →

Medicare billing

Part B allowed, 2024

$90,711

Medicare patients

625

Services billed

1,344

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	16	$23,609
Dofetilide	43	$8,151
Metoprolol Succinate	14	$240

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in San Francisco

Daniel MorinSan Francisco$265K
Henry HsiaSan Francisco$231K
Edward GerstenfeldSan Francisco$211K
Joshua MossSan Francisco$138K
Shephal DoshiSanta Monica$2.1M
Jonathan HsuSan Diego$1.2M
Leslie SaxonLos Angeles$1.1M
Rahul BhardwajLoma Linda$935K
Nicholas Olsonla Jolla$801K
Jonathan DukesVentura$775K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →